MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,582,000 | -18.6% | 149,831 | -18.9% | 0.03% | -22.0% |
| Q1 2021 | $5,628,000 | +98.1% | 184,827 | +28.6% | 0.04% | +70.8% |
| Q4 2020 | $2,841,000 | -16.1% | 143,679 | -44.7% | 0.02% | -14.3% |
| Q3 2020 | $3,387,000 | -41.1% | 259,739 | -48.8% | 0.03% | -57.6% |
| Q2 2020 | $5,748,000 | +1230.6% | 506,870 | +1577.4% | 0.07% | +450.0% |
| Q1 2020 | $432,000 | -38.1% | 30,217 | +25.8% | 0.01% | -62.5% |
| Q4 2018 | $698,000 | -82.8% | 24,023 | -72.8% | 0.03% | -63.6% |
| Q3 2018 | $4,058,000 | +23.3% | 88,221 | +0.1% | 0.09% | 0.0% |
| Q2 2018 | $3,292,000 | +161.1% | 88,090 | +140.0% | 0.09% | +225.9% |
| Q4 2017 | $1,261,000 | – | 36,710 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |